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Abstract
Background: Amyotrophic lateral sclerosis (ALS), the most frequent adult onset motor neuron disease, is associated with
hypermetabolism linked to defects in muscle mitochondrial energy metabolism such as ATP depletion and increased
oxygen consumption. It remains unknown whether muscle abnormalities in energy metabolism are causally involved in the
destruction of neuromuscular junction (NMJ) and subsequent motor neuron degeneration during ALS.
Methodology/Principal Findings: We studied transgenic mice with muscular overexpression of uncoupling protein 1
(UCP1), a potent mitochondrial uncoupler, as a model of muscle restricted hypermetabolism. These animals displayed age-
dependent deterioration of the NMJ that correlated with progressive signs of denervation and a mild late-onset motor
neuron pathology. NMJ regeneration and functional recovery were profoundly delayed following injury of the sciatic nerve
and muscle mitochondrial uncoupling exacerbated the pathology of an ALS animal model.
Conclusions/Significance: These findings provide the proof of principle that a muscle restricted mitochondrial defect is
sufficient to generate motor neuron degeneration and suggest that therapeutic strategies targeted at muscle metabolism
might prove useful for motor neuron diseases.
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Introduction
Amyotrophic lateral sclerosis (ALS) is the most frequent form of
motor neuron disease in the elderly. Although most ALS cases
occur sporadically, without known family history, a subset of these
are genetically inherited. In particular, twenty percent of familial
ALS cases are linked to mutations in the gene encoding the
antioxidant enzyme Cu/Zn superoxide dismutase (SOD1).
Transgenic mice expressing mutant forms of SOD1 (mSOD1
mice) recapitulate the phenotype of ALS and provide the only
currently available faithful model of ALS [1,2].
The mechanisms underlying the selective motor neuron
degeneration in ALS remain elusive. Recent work in mSOD1
mice showed that motor neuron death is not cell autonomous
and involves defects in other cell types than neurons [3,4].
Consistent with this notion, recent evidence showed that the
pathophysiology of ALS includes widely systemic defects in both
patients and animal models. In particular, energy homeostasis is
strikingly abnormal in ALS patients since both sporadic and
familial ALS patients present with increased energy expenditure
(hypermetabolism) and hyperlipidemia [5–8]. These systemic
defects are in some yet unknown way linked to the disease
process since hyperlipidemia correlates with increased survival in
ALS patients [7]. Our work in animal models showed that
mSOD1 mice were in energy deficit, with decreased adipose
stores [9,10]. This condition was elicited by increased energy
expenditure, ie hypermetabolism, and was due to an increased
consumption of both glucid and lipid nutrients in skeletal muscle
[9,10]. Early reduced muscle ATP levels, long before the onset of
motor impairment further indicates impaired fuel processing
[11]. Feeding these animals with a fat enriched diet replenished,
to some extent, adipose stores and, most importantly, increased
the lifespan and delayed muscle denervation of transgenic
mSOD1 mice [9,12]. Thus, ALS is associated with alterations
of energy homeostasis which interferes with the pathological
process.
PLoS ONE | www.plosone.org 1 April 2009 | Volume 4 | Issue 4 | e5390Whether muscle hypermetabolism is sufficient per se to drive
motor neuron degeneration remains however unknown. To
address this question, we used here transgenic mice with muscular
overexpression of uncoupling protein 1 (UCP1), a mitochondrial
protein typically present in brown adipose tissue that induces non-
shivering thermogenesis by uncoupling mitochondrial electron
transport from ATP synthesis [13,14,15]. These animals naturally
displayed an age-dependent deterioration of both the presynaptic
and postsynaptic compartments of the neuromuscular junction
(NMJ), and progressive signs of denervation that eventually led to
mild late-onset motor neuron pathology in the spinal cord. NMJ
regeneration and functional recovery were profoundly delayed
following injury to the sciatic nerve and mutant SOD1 pathology
was exacerbated by muscle UCP1 expression. These findings show
that a relatively mild mitochondrial dysfunction in muscle
recapitulates the earliest pathological events in ALS.
Results
Mitochondrial uncoupling leads to muscle weakness but
preserves muscle structure
To achieve a chronic muscle-restricted uncoupling, we used
mice overexpressing UCP1 under the control of the promoter of
the muscle creatine kinase (MCK) gene. Previous work on these
MCK-UCP1 mice had shown slight decreases in both mitochon-
drial membrane potential (from 170 mV to 160 mV) and
respiratory control ratio (from 3.3 to 2.5), which resulted in a
mild phenotype primarily characterized by diminished muscle
mass and fast-to-slow muscle fiber type switching in muscles such
as the gastrocnemius [14]. As a first step toward the character-
ization of the neuromuscular phenotype in these animals, we
sought to replicate and extend these results. Consistent with this,
w ef o u n dt h a tM C K - U C P 1m i c ew e r el i g h t e r( f i g u r e1 A ) ,a n d
the cross-sectional surface of gastrocnemius myofibers showed a
dramatic age-dependent reduction (figure 1C), which could
account for their decreased grip strength (figure 1B). Since Han
and collaborators [16] had previously reported that mice
overexpressing high levels of UCP1 suffer from a prominent
myopathic disorder, we checked whether the reduction in muscle
fiber size observed in our animals could reflect a degenerative
process. Serum concentrations of creatine kinase and lactate, an
increase of which is indicative of muscular dystrophy [17], were
not increased in MCK-UCP1 mice but rather tended to
decrease, as compared to wild-type littermates (figure 2A). In
addition, we did not detect the presence of myofibers containing
centrally located nuclei (data not shown), that would be a sign of
the regenerative process observed in muscular dystrophy [17]. In
agreement with these findings, MCK-UCP1 muscles did not
upregulate the satellite cell marker M-Cadherin, which is
typically found in such regenerative processes (figure 2B).
Necrotic myofibers, another hallmark of muscular dystrophy
[17], can be easily identified by their permeability to Evans blue
dye. In control experiments, a huge amount of Evans blue
positive myofibers were observed in wild-type muscles following
cardiotoxin injury, but only very few atrophic myofibers (less
than 1 per field) were detected in 7-month-old MCK-UCP1 mice
Figure 1. Muscle phenotype of MCK-UCP1 mice. A: body weight of male (empty diamonds) and female (empty triangles) wild-type mice, and
male (filled diamonds) and female (filled triangles) MCK-UCP1 mice as a function of time. *, p,0.05 vs corresponding MCK-UCP1 (n=7 mice per
group). B: grip strength of mice as in A.* ,p ,0.05 vs corresponding MCK-UCP1 C: representative photomicrographs showing hematoxylin and eosin
staining of gastrocnemius from wild-type mice (Wt) or MCK-UCP1 mice at 3 months (3 m) and 7 months (7 m) of age. The right panel shows the
quantification of mean fiber area. *, p,0.05 (n=4 mice per group).
doi:10.1371/journal.pone.0005390.g001
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ligase whose expression is strongly upregulated upon muscle
wasting [18], appeared unchanged in MCK-UCP1 mice, as
compared to wild-type littermates (figure 2B). Altogether, these
findings confirm that mild mitochondrial uncoupling in MCK-
UCP1 mice does not cause a dystrophic or massive proteolytic
degeneration in skeletal muscle.
Muscle mitochondrial uncoupling affects the integrity of
AchR clustering
We next studied in detail the morphology of the NMJ in both 1-
and 7-month-old mice. In wild-type muscle fibers, AchR clusters
were organized in a classical pretzel-shaped structure, either at 1
(figure 3A, picture a and b) or 7 months of age (figure 3A, picture c
and d). In contrast, the postsynaptic primary gutters in MCK-
UCP1 fibers appeared less ramified already at 1 month of age
(figure 3A, pictures e-h), and, in very rare cases, fragmented
(figure 3A, picture h). At 7 months of age, fragmentation was very
frequent, and the size of the postsynaptic apparatus had decreased,
as compared to wild-type mice (figure 3A, pictures i–l). Moreover,
in the few NMJs presenting with normal primary gutters at this
age, thinner cisternae (arrowhead in figure 3A, picture i) and
neighboring ectopic AchR clusters (asterisks in figure 3A, picture i)
could be detected. Quantitative analysis of these phenomena
corroborated the histological observations and revealed a
Figure 2. MCK-UCP1 do not display muscle dystrophy. A: serum creatine kinase (left panel) and lactate (right panel) concentrations in wild-
type (Wt) or MCK-UCP1 mice at 2 months (2 m) and 7 months (7 m) of age. Non-significant differences (n=8 mice per group). B: mRNA levels of
atrogin-1 and M-cadherin in gastrocnemius from wild-type (empty circles) or MCK-UCP1 (black circles) mice at perinatal (PN), 1 month (1 m) and 7
months (7 m) of age. *, p,0.05 vs corresponding wild-type (n=3–8 mice per group). C: representative photomicrographs showing hematoxylin and
eosin staining of gastrocnemius from cardiotoxin-injured (48 hours after injury, CTX), wild-type (Wt) or MCK-UCP1 mice at 3 months (3 m) and 7
months (7 m) of age. Three mice per group were analyzed. A necrotic myofiber is indicated by an arrow. D: Evans blue dye staining as visualised by
fluorescence in gastrocnemius from cardiotoxin-injured (48 hours after injury, CTX), wild-type (Wt) and MCK-UCP1 mice at 3 months (3 m) and 7
months (7 m) of age. Three mice per group were analyzed. Only a few necrotic myofibers could be detected in 7-month-old MCK-UCP1 mice (arrow).
doi:10.1371/journal.pone.0005390.g002
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(figure 3B). In all, these findings indicate that NMJ morphology
progressively deteriorates with age upon chronic muscle mito-
chondrial uncoupling.
Muscle mitochondrial uncoupling triggers abnormal
muscle electrical activity
Next we asked whether the morphological abnormalities of the
postsynaptic apparatus in MCK-UCP1 mice could be secondary
to muscle denervation. To this end, we performed longitudinal
electromyography studies. Before 6 weeks of age, MCK-UCP1
mice showed normal electrical activity recordings, as compared to
wild-type animals (figure 4A), suggesting that NMJs were
functional and properly innervated at that age. Later on, however,
a subset of mice started to exhibit fasciculations, which gradually
progressed in older animals to strongly altered patterns charac-
terized by fibrillations, fasciculations and myotonic discharges
(figure 4A). After 7 months of age, all the mice were affected
(figure 4B). To test whether this abnormal electrical activity was
the reflect of altered neurotransmission at the NMJ, as occurs for
example in congenital myasthenic syndromes, we recorded the
muscle evoked response to repetitive nerve stimulation. If
neuromuscular transmission was affected, a sharp decrease
Figure 3. Aging MCK-UCP1 mice show progressive NMJ deterioration. A: representative photomicrographs showing NMJ morphology in
gastrocnemius from wild-type (Wt) or MCK-UCP1 mice. Note the pretzel-shaped morphology of wild-type NMJs either at 1 month (a, b) or 7 months
of age (c, d). In 1-month-old (1 m) MCK-UCP1 mice, NMJs appeared smaller and, in some rare cases, fragmented (e-h). At 7 months of age (7 m),
thinner cisternae (arrow in i), ectopic AchR clusters (star in i), fragmented NMJs (j,k) and degenerated postsynaptic apparatus (l) were observed. Scale
bar, 20 mm. B: quantitative morphometry of NMJs in gastrocnemius from wild-type (empty columns) or MCK-UCP1 (black columns) mice at 1 month
(1 m) and 7 months (7 m) of age. *, p,0.05 vs corresponding wild type (n=5 mice per group).
doi:10.1371/journal.pone.0005390.g003
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observed after repeated stimulations, but no differences were
detected between MCK-UCP1 and wild-type mice (figure 4C),
indicating that neuromuscular transmission did not appear
compromised. Additionally, we measured caudal sensory nerve
velocity to determine whether sensory abnormalities could be
observed, but found no changes in MCK-UCP1 mice (figure 4D).
Muscle mitochondrial uncoupling triggers endplate
denervation and distal axonal degeneration
The presence of abnormal electromyography patterns together
with the observed morphological changes in the postsynaptic
apparatus from old MCK-UCP1 mice could reflect denervation.
Immunohistochemical analysis of the pre- and postsynaptic
compartments of the NMJ revealed complete overlapping of
synaptophysin and alpha-bungarotoxin staining in 1-month-old
MCK-UCP1 mice, whereas 60% of the alpha-bungarotoxin
positive NMJs in 7-month-old MCK-UCP1 mice lacked synapto-
physin labeling (figure 5A–B), thus suggesting loss of the
presynaptic button. To further confirm these observations, muscle
sections were stained with an antibody directed against p75NTR,
which is typically overexpressed in Schwann cells surrounding
degenerating motor endings [19]. p75NTR positive nerve fibers
were systematically detected in old, but not young, MCK-UCP1
mice (figure 5C). Altogether, these findings show that MCK-UCP1
mice are afflicted by a distal, age-related axonopathy.
Muscle mitochondrial uncoupling triggers spinal cord
astrocytosis and mild motor neuron degeneration
The existence of a NMJ pathology in aging MCK-UCP1 mice
prompted us to determine whether any abnormalities could be
detected in the ventral root axons and their corresponding spinal
cord motor neuronal cell bodies. Ventral roots from MCK-UCP1
mice appeared grossly normal, but showed sparse axonal
degeneration (figure 6A). A more detailed analysis of the
distribution of axonal calibers revealed an almost 50% reduction
in the amount of large (.5 micrometers in diameter) caliber
axons, together with a concomitant increase in the amount of very
small caliber, presumably degenerating axons (figure 6B–C).
Motor neuron counting was performed in the ventral horns of
the lumbar spinal cord at 3 and 7 months of age, by means of a
morphometric approach based on the cross-sectional area of the
cells (figure 6D, left) or by direct identification of choline
acetyltransferase positive motor neurons (figure 6D, right). Both
methods demonstrated a significant 20–30% decrease in the
number of motor neurons in 7-month-old MCK-UCP1 mice, as
compared to 3-month-old MCK-UCP1 or wild-type animals. The
presence of astrocytosis in the lumbar spinal cord, which is
typically associated with neuronal suffering [20], was assessed
using an antibody directed against the astrocyte marker GFAP. An
increase of GFAP positive astrocytes was observed in 7-month-old
MCK-UCP1 mice, as compared to wild-type littermates
(figure 6E). In all, these findings strongly suggest that chronic
muscle-restricted mitochondrial uncoupling is able to induce a
mild but clear motor neuron pathology, likely as a result of the
progressive degenerative process initiated at the NMJ.
Muscle mitochondrial uncoupling strongly increases
agrin-induced AchR clustering
The first pathological event observed in MCK-UCP1 mice
appeared to be the dismantlement of the post-synaptic apparatus.
Since acetylcholine receptor (AchR) clustering is likely to be an
energy-dependent process, we hypothesized that mitochondrial
uncoupling occuring in MCK-UCP1 muscles lead to an inability
of these muscles to maintain AchR clusters with age. To test this
hypothesis, we determined whether old MCK-UCP1 mice were
still able to newly form ectopic AchR clusters. Neural agrin, via
activation of muscle specific kinase (MuSK), is responsible for
NMJ formation and stability [21], and is known to trigger ectopic
AchR clustering upon intramuscular injection, the response being
Figure 4. Electromyographic features of MCK-UCP1 mice. A: representative electromyography recordings in gastrocnemius from a 7-month-
old wild-type mouse (left panel), and two 7-month-old MCK-UCP1 mice showing weak (middle panel) and intense (right panel) altered electrical
activity. B: fraction of mice presenting with aberrant spontaneous denervation activity in at least one muscle territory. Wild-type mice (empty
triangles), MCK-UCP1 mice (filled triangles) (n=6–10 mice per group). C: decrement observed in a repetitive stimulation test in gastrocnemius from 7-
month-old wild-type (Wt) and MCK-UCP1 mice (n=6 mice per group). D: sensory nerve velocity in 7-month-old wild-type (Wt) and MCK-UCP1 mice
(n=6 mice per group).
doi:10.1371/journal.pone.0005390.g004
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denervated muscle, intramuscular injection of agrin stimulated
ectopic AchR clustering much more efficiently in MCK-UCP1
mice than in wild-type animals, the largest clusters being observed
in innervated MCK-UCP1 muscle (figure 7). In particular, large
AchR clusters were frequently detected in the extra junctional area
in MCK-UCP1 muscle fibers, whereas only small AchR clusters
could be observed and were closely confined to the synaptic region
in wild-type fibers. These findings show that, contrary to our initial
hypothesis, aged MCK-UCP1 mice are still able to efficiently
respond to NMJ-inducing stimulatory nerve factors and suggest
that the NMJ defects of these mice are rather presynaptic.
Muscle mitochondrial uncoupling delays motor recovery
after lesion
Since AchR clustering is efficiently maintained in MCK-UCP1
mice, we assessed whether axonal regeneration upon injury was
normal. To this aim, we performed sciatic nerve crush studies.
This experimental model is typically characterized by axonal
degeneration and subsequent reinnervation, generally completed
within 2 weeks post-lesion. After nerve crush, motor recovery was
evaluated by the sciatic functional index (SFI), a scale based on the
shape of footprints, and grip strength [22]. In wild-type mice, the
SFI decreased to a minimum 3 days post-operation and then
progressively recovered to reach a normal value at day 15. In
MCK-UCP1 mice, the decrease of the SFI was much more
pronounced, and recovery was greatly delayed and hardly
completed 30 days after lesion (figure 8A). Consistent with this,
grip strength of the operated limb showed a quite similar evolution
(figure 8B). In addition, the accompanying recovery of muscle
mass, which was complete 1 month post-operation in wild-type
mice, appeared significantly impaired in MCK-UCP1 animals
(figure 8C). To determine whether the retardation in functional
recovery was due to delayed reinnervation, we performed double
neurofilament/synaptophysin immunostaining along with alpha-
bungarotoxin labeling to examine the aspect of the NMJs after
nerve crush. NMJs from operated wild-type mice had almost
completely recovered 8 days after lesion, whereas most NMJs in
MCK-UCP1 mice remained denervated and appeared smaller
(figure 8D–E). Altogether, these findings show that mitochondrial
uncoupling in skeletal muscle limits considerably axonal regener-
ation after lesion.
Muscle mitochondrial uncoupling exacerbates motor
neuron disease in mice
To further explore the negative influence of muscle mitochon-
drial uncoupling on motor neuron degeneration, we analysed
whether muscle UCP1 overexpression could change the pattern of
disease in a transgenic mouse model of amyotrophic lateral
sclerosis (ALS). To this end, we crossbred MCK-UCP1 mice with
Figure 5. Aging MCK-UCP1 mice show progressive denervation and distal axonal degeneration. A: representative photomicrographs
showing AchR (red) and synaptophysin (green) staining in gastrocnemius from wild-type (Wt) or MCK-UCP1 mice at 1 month (1 m) and 7 months
(7 m) of age. Scale bar, 20 mm. B: quantification of the percentage of synaptophysin positive NMJs as shown in D,* ,p ,0.05 vs wild-type. (n=4 mice
per group). C: representative photomicrograph showing p75NTR immunostaining in gastrocnemius from 7-month-old wild-type (Wt) or MCK-UCP1
mice. Scale bar, 20 mm.
doi:10.1371/journal.pone.0005390.g005
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mutated form of Cu/Zn-superoxide dismutase [23,24]. To
monitor disease progression, we followed the characteristic decline
in peak body mass observed in these animals as the earliest
symptom that coincides with initial axonal retraction from NMJs.
Then, we defined an early stage of disease as the time from onset
until maximals body mass has decreased by 10% ([3,9] and our
own observations on the SOD1(G86R) mouse line). Based on
these criteria, no differences were detected in disease onset
(figure 9A). However, both progression from onset through early
disease (figure 9B) and total survival (figure 9C) were significantly
shortened in heterozygous SOD1(G86R)/MCK-UCP1 mice, as
compared to SOD1(G86R) mice (figure 9D). Altogether, these
data indicate that muscle-specific mitochondrial uncoupling is, in
itself, sufficient to deteriorate NMJ stability and hence contribute
to the progression of motor neuron disease.
Discussion
This study demonstrates that a mild uncoupling of mitochon-
drial respiration in skeletal muscle profoundly affects NMJ stability
and function and leads to distal degeneration of motor neurons.
These findings show that muscle mitochondria are crucially
involved in NMJ maintenance and are potentially relevant to the
pathophysiology of MNDs.
Muscle uncoupling leads to distal axonopathy and late
onset motor neuron degeneration
Mild muscle-restricted mitochondrial uncoupling had little
effect on muscle overall structure, despite reduced mass and mild
mitochondrial myopathy (Han and our data not shown). In young
mice, mitochondrial uncoupling did not appear to interfere with
the development of a normal, pretzel-shaped innervated NMJ.
However, as shown here by using a combination of histological
and electrophysiological techniques, these NMJs progressively
underwent denervation upon aging. This in turn leads to a distal
axonopathy that progressed with age to a limited but clear motor
neuron degeneration. Our results indicate that the progressive
deterioration of NMJs in aging MCK-UCP1 mice results from an
intrinsic instability of the axon rather than from a post-synaptic
dismantlement of the NMJ. Two lines of results are consistent with
this notion. First, the formation of AchR clusters in response to
neural agrin was not impaired but rather enhanced in MCK-
Figure 6. Mild late onset motor neuron degeneration in MCK-UCP1 mice. A: representative photomicrographs showing ventral roots from
wild-type (Wt) and MCK-UCP1 mice. Note the presence of two degenerating axons in the MCK-UCP1 picture (arrows). B: distribution of the calibers of
axons in the ventral roots from wild-type (empty circles) or MCK-UCP1 (filled circles) mice. Small-caliber axons represent gamma-axons, which
innervate muscle spindles, whereas large-caliber axons represent alpha-axons, which innervate skeletal muscles. Note the decrease in the population
of the largest caliber axons in MCK-UCP1 ventral roots. C: size distribution of axons in the ventral roots from 7-month-old wild-type (empty columns)
and MCK-UCP1 (filled columns) mice. *, p,0.05 vs wild-type (n=3 mice per genotype). D: quantification of the number of motor neurons in the
lumbar spinal cord form wild-type (Wt) and MCK-UCP1 (MCK-UCP1) mice at 3 months (3 m) and 7 months (7 m) of age, after toluidine blue-staining
(left panel) and ChAT immunoreactivity (right panel). *, p,0.05 vs wild-type (n=5 mice per group). E: representative photomicrographs showing
GFAP immunoreactivity in the lumbar spinal cord from 7-month-old wild-type (Wt) or MCK-UCP1 mice. Ventral horns are indicated by dashed lines.
Scale bar, 20 mm.
doi:10.1371/journal.pone.0005390.g006
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muscular machinery responsible for AchR clustering is not
impaired. Second, functional recovery after nerve injury was
considerably delayed in MCK-UCP1 muscles (figure 8), suggesting
a rather inefficient nerve terminal regeneration and a severe
impairment of the presynaptic mechanisms that underlie axonal
regrowth. A very plausible explanation for the progressive
denervation and impaired reinnervation observed in MCK-
UCP1 mice is that mitochondrial uncoupling in muscle modifies
the production of retrograde signals required for presynaptic
motor ending stability. Since, at present, little is known on the
nature of the signals produced by an adult muscle fiber to maintain
the stability of the neuromuscular contact, the precise signalling
mechanisms elicited by mitochondrial uncoupling and their
relative contribution to the pathology of these mice will require
further investigations. Such studies will undoubtly shed light on
new retrograde muscle to nerve survival signalling pathways. It is
important to note that our current results are compatible with two
pathological scenarios: first, the NMJ alterations might be due to
cell autonomous effects of transgene expression. In this scenario,
mitochondrial uncoupling in a given muscle fiber would locally
lead to the degeneration of its innervating axon. Alternatively,
since transgene expression in muscles leads to broadly systemic
effects, these systemic alterations could weaken NMJs and
neuromuscular contacts. Indeed, caloric restriction is able to
accelerate the outcome in mSOD1 mice [25], suggesting that
interventions ameliorating systemic energy metabolism might also
weaken motor neurons.
Muscle mitochondrial uncoupling does not lead to
paralysis or premature death
Although displaying a massive destruction of the NMJs, MCK-
UCP1 mice do not display a full blown fatal motor neuron disease.
This apparently paradoxical situation may rest on the fact that not
all the muscles in MCK-UCP1 mice are affected by UCP1
overexpression. In fact, numerous muscles beds, including the
soleus, the diaphragm and heart muscles appeared relatively
normal in these animals, despite that they express almost
equivalent levels of UCP1 protein than in severely affected
muscles such as the gastrocnemius or the tibialis anterior muscles
([14] and data not shown). From their seminal observations,
Couplan and collaborators concluded that muscles undergoing
regular contractions, and therefore resting on a continuous
mitochondrial ATP production, are protected from the uncou-
pling activity of UCP1 [14]. This is consistent with the idea that
regular contractions trigger a sustained low mitochondrial
potential in these muscles that inhibits the protonophoric activity
of UCP1. Thus, despite being overexpressed in all muscles, the
transgene only affects fast-twitch fibers, which are predominant in
the gastrocnemius [13,14]. This tissue-restricted pathology is likely
to explain why the phenotype described here is compatible with a
normal lifespan and has not been reported before.
Does skeletal muscle contribute to motor neuron
degeneration in ALS?
Our data suggest that muscle selective alterations in mitochon-
drial function might initiate NMJ pathology and participate in
triggering motor neuron degeneration in ALS. The pathology of
MCK-UCP1 mice begins with NMJ destruction and distal
axonopathy and then progresses towards astrocytosis in the spinal
cord and mild motor neuron loss, both typical features of motor
neuron diseases. Importantly, in ALS too, the destruction of the
NMJ appears as the first detectable pathophysiological event and
precedes axonal degeneration and motor neuron death in mutant
SOD1 mice [26]. In MCK-UCP1 mice, NMJ destruction is due to
a muscle specific alteration in mitochondrial function and similar
alterations have been documented in the muscle of both sporadic
ALS patients and mutant SOD1 mice [27]. Mitochondrial
dysfunction in muscle might be either directly caused by mutant
SOD1 expression in muscle or indirectly through mutant SOD1
expression in other cell types. Consistent with the first hypothesis,
a recent study by Dobrowolny and collaborators showed that
restricted mutant SOD1 expression in muscle is sufficient to
trigger muscle atrophy and mitochondrial dysfunction. Similar to
the situation in MCK-UCP1 mice, muscle restricted expression of
mutant SOD1 triggered some of the pathological aspects of ALS in
the spinal cord, including oxidative stress and gene expression
profiles consistent with microgliosis [28]. In view of the parallel
phenotypes between mutant SOD1 and MCK-UCP1 mice, one
can suggest that mutant SOD1 expression in skeletal muscle is able
to trigger axonal degeneration through the direct implication of
mitochondria. This hypothesis is however not completely
consistent with the available evidence. Two studies showed that
a loss of mutant SOD1 expression in muscle did not change
disease outcome in mutant SOD1 mice [29,30], suggesting that
either minute quantities of remaining mSOD1 in muscle are still
sufficient to trigger the disease or that the knockdown of mutant
SOD1 in muscle was performed too late in the course of the
pathology. Whatever the exact contribution of muscle mSOD1 to
mitochondrial dysfunction in these mice, the elucidation of the
mechanisms underlying motor neuron pathology in MCK-UCP1
mice shed light on the early pathological events of ALS and might
Figure 7. Old MCK-UCP1 mice show increased AchR clustering
in response to agrin. representative photomicrographs showing
AchR clusters in contralateral (innervated) and ipsilateral (denervated)
tibialis anterior from wild-type (Wt) or MCK-UCP1 mice 8 days after
sciatic nerve axotomy and 15 days after recombinant agrin injection.
Scale bar, 20 mm.
doi:10.1371/journal.pone.0005390.g007
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other motor neuron disorders.
Materials and Methods
Animals and surgery
Heterozygous MCK-UCP1 mice were bred on the original
genetic background and identified by tail DNA genotyping as
previously described [14]. Transgenic mice expressing the murine
G86R SOD1 mutation were obtained in our animal facility and
genotyped as described [9]. Disease monitoring was performed
according to previous reports [3,9]. Wild-type littermates served as
controls. Animals were maintained on a 12 h light/12 h dark
cycle, and received food and water ad libitum. For histological
analysis of spinal cord tissue, animals were deeply anesthesized
with 1 mg/kg body weight ketamine chlorhydrate and 0.5 mg/kg
body weight xylazine, and transcardially perfused with 4%
paraformaldehyde in 0.1 M phosphate buffer pH 7.4. Tissues
were then quickly dissected, post-fixed in 4% paraformaldehyde
for 24 hours, and cryoprotected with 30% sucrose in PBS for
48 hours before cryostat sectioning. For histological analysis of
muscle tissue, samples were fresh dissected and frozen in melting
isopentane in dry ice. For biochemical analysis, animals were
sacrificed and tissues were quickly dissected, snap frozen in liquid
nitrogen and stored at 280uC until use. Sciatic nerve crush and
axotomy were performed as described [31]. Briefly, mice were
anesthesized as mentioned above, and hind limb skin was carefully
shaved and incised at the mid thigh level. Sciatic nerve was
exposed and either cut or crushed during 30 seconds. Skin was
sutured, and animals were allowed to recover. Animal manipu-
lation followed current EU regulations and was performed under
the supervision of authorized investigators.
Analysis of motor function
Grip strength measurements were performed using a Bioseb
gripmeter following the manufacturer’s instructions. Data were the
mean of three successive trials per mouse. Grip strength was
measured on the four limbs or on each individual hind limb for
evaluation of functional recovery following sciatic nerve crush.
The sciatic functional index (SFI) was calculated using the
Figure 8. MCK-UCP1 mice show delayed functional recovery after nerve crush. A–B: Sciatic functional index (A) and grip strength (B)i n1 -
month-old wild-type (empty diamonds) or MCK-UCP1 mice (filled diamonds) after sciatic nerve crush, performed at day 0. Grip strength was
expressed as the percentage of ipsilateral strength relative to the contralateral limb. *, p,0.05 vs corresponding wild type; #,p ,0.05 vs day 0 (n=12
mice per group). C: Mass of contralateral (empty columns) and ipsilateral (black columns) gastrocnemius from wild-type (Wt) or MCK-UCP1 mice 30
days after sciatic nerve crush. *, p,0.05 vs contralateral muscle (n=5 mice per group). D: quantification of the percentage of synaptophysin positive
NMJs as shown in E,* ,p ,0.05 vs wild-type. (n=5 mice per group). E: representative photomicrographs showing AchR (red) and neurofilament/
synaptophysin (green) staining in contralateral and ipsilateral gastrocnemius from wild-type (Wt) or MCK-UCP1 mice 8 days after sciatic nerve crush
(e) and quantification of the experiment (d). Note the denervated endplates (stars) and the retracted nerve fibers (arrowheads). Scale bar, 20 mm.
doi:10.1371/journal.pone.0005390.g008
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and collaborators [22].
Biochemical measurements
Plasma was collected on heparinized capillaries, and lactate and
creatine kinase levels were measured following standard clinical
protocols.
Skeletal muscle histology
Cryostat cross-sections 20 mm thick of gastrocnemius muscle
were stained with hematoxylin and eosin using a standard
protocol. For detection of necrotic myofibers, mice were
intraperitoneally injected with 1% Evans Blue dye in saline as
described [32]. Briefly, 16 hours after injection, mice were
sacrificed, and muscles were immediately frozen in melting
isopentane and cut in a cryostat. Sections were dipped into cold
acetone, dried and mounted in non-fading medium until
observation.
Analysis of neuromuscular junction morphology
Unless otherwise indicated, muscle bundles were prepared
under a binocular microscope, and labeled with rhodamine-
conjugated alpha-bungarotoxin (Sigma, Saint-Quentin Fallavier,
France) and Hoechst dye. When necessary, longitudinal sections of
gastrocnemius muscle 40-mm thick were co-stained with rhodamine-
conjugated alpha-bungarotoxin and antibodies directed against
synaptophysin (Dako, Trappes, France), neurofilament (Sigma,
Saint-Quentin Fallavier, France) or p75NTR (Chemicon Interna-
tional, Hampshire, UK), using a standard protocol as previously
described [33]. Usually, 5–6 non-adjacent sections were examined
per animal, which represented 100–150 analyzed NMJs per animal.
Lower motor neuron counting
Motor neuron counts were obtained from the ventral horns of
the lumbar spinal cord segments L3–L5, using at least 7 non-
adjacent sections 10-mm thick per animal examined in a Nikon
microscope at a 2006 magnification [9]. Sections were stained
with 1% toluidine blue in 5% sodium borate, and the cross-
sectional areas of the stained cells were measured with the NIH
Image software. Only those cells with an area $600 mm
2 were
considered as motor neurons. In a parallel set of sections, motor
neurons were identified by immunostaining with an antibody
directed against choline acetyltransferase (ChAT; Chemicon
International). Counts of ChAT positive motor neurons were
performed by an independent genotype-blinded observer.
Electromyography
Electromyography recordings were made using a standard
apparatus (Dantec, Les Ulis, France) as previously described [33].
Mice were anesthetized as mentioned above, and a monopolar
needle electrode (diameter 0.3 mm; 9013R0312; Medtronic,
Minneapolis, MN) was inserted into the tail of the mouse to
ground the system. Recordings were made with a concentric
needle electrode (diameter 0.3 mm; 9013S0011; Medtronic).
Electrical activity was monitored on gastrocnemius muscles at
both right and left sides for at least 2 min. Spontaneous activity
Figure 9. UCP1 overexpression exacerbates motor neuron disease in mice. A–C: Kaplan-Meier curves showing the cumulative probability
of disease onset (age at the peak of body mass prior to decline, A), progression through early disease stage (when maximal body mass decreases by
10%, B), and total survival (C). The p-values, as calculated using the logrank test, are shown. D: duration of early disease stage (left) and total duration
of disease (right) in SOD1(G86R) mice (empty columns) and compound SOD1(G86R)/MCK-UCP1 mice (filled columns). *, p,0.05 vs corresponding
SOD1(G86R).
doi:10.1371/journal.pone.0005390.g009
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inspection. Voluntary activity is characterized by rather repetitive
regular discharges, which disappear with relaxation of the muscle.
Only spontaneous activity with a peak-to-peak amplitude of at
least 50 mV was considered to be significant. The repetitive nerve
stimulation test was performed to assess neuromuscular transmis-
sion. Supramaximal square pulses, of 0.2 ms duration, were
delivered through a needle electrode to the sciatic nerve at the
sciatic notch level. An anode needle was inserted at the base of the
tail. The active recording needle electrode was inserted in the
medial part of the gastrocnemius. Reference recording needle
electrode was inserted over the Achilles tendon. The myoelectric
signal was bandpass filtered (2 Hz–5 kHz) to eliminate artefacts.
First, one set of 5, 3-Hz supramaximal stimulations was delivered
continuously; CMAPs were recorded simultaneously for the same
period. A decrease of more than 10% in the amplitude of the fifth
evoked response compared to the initial (first) response was defined
as a significant decremental response to a supramaximal
stimulation. To elicit the sensory nerve action potential, the tail
was strapped to a polystyrene board. The monopolar needle
electrodes were inserted as follows: (a) the stimulating cathode was
placed exactly two-thirds of the length of the tail, distally to its
hairline, (b) the stimulating anode was inserted 3 mm distal to the
stimulating cathode, (c) the recording cathode and anode were
inserted 5 and 2 mm distal to the hairline of the tail, respectively,
and (d) a ground electrode was inserted half way between the
stimulating and the recording cathodes. Ten responses were
averaged for each recording. The sensory NCV of the tail nerve
was calculated from the latency of the stimulus artifact to the onset
of the negative peak of the action potential elicited and the
distance between the stimulating and the recording cathodes.
Real time RT-PCR
Total RNA was extracted from gastrocnemius using Trizol
(Invitrogen, Cergy-Pontoise, France) according to the manufac-
turer’s instructions. cDNA synthesis was performed using 1 mgo f
total RNA (iScript cDNA Synthesis kit; Bio-Rad, Marne La
Coquette, France). PCR analysis was carried out on a Bio-Rad
iCycler System using iQSYBR Green Supermix. A specific
standard curve was performed in parallel for each gene, and each
sample was quantified in duplicate. PCR conditions were 3 min at
94uC, followed by 40 cycles of 45 s at 94uC and 10 s at 60uC. Data
were analyzed using the iCycler software, and normalized to the
18S ribosomal subunit RNA.
Recombinant agrin injections
Chicken neural mini-agrin [34] was cloned into the pCEP-Pu
expression vector. The recombinant protein was targeted to the
secretory pathway by the signal peptide of BM4O and it included
a carboxy-terminal His6-tag. The carboxy-terminal included the
4- and 8-amino-acid inserts at the A/y and B/z sites and thus
represents the neural isoform. The secreted recombinant agrin was
purified on Ni-column (Ni-NTA agarose, Qiagen) from the culture
medium of 293 EBNA cells stably transfected with the pCEP-Pu-
agrin vector. Mice were anesthesized as mentioned above, and the
tibialis anterior was bilaterally injected with 500 ng of recombi-
nant agrin. Seven days after injection, mice were subjected to
unilateral sciatic nerve axotomy and were sacrificed seven days
after. Tibialis anterior muscles were immersed in 4% paraformal-
dehyde during 30 min and stored in PBS until use. Muscle bundles
were prepared and stained for AchR as previously described.
Statistical analysis
Data are expressed as the mean6SEM. Statistical analysis was
accomplished using Student t-test or ANOVA followed by Tukey-
Kramer multiple comparisons test. The logrank test was applied to
compare Kaplan-Meier curves (PRISM version 4.0b; GraphPad,
San Diego, CA). Differences at P,0.05 were considered
significant.
Acknowledgments
We acknowledge the skillful technical assistance of Marie-Jose ´ Ruivo, and
Annie Picchinenna and the technical help of Muriel Hoering, Je ´rome
Sinniger and Charlotte Dreyer.
Author Contributions
Conceived and designed the experiments: LD JPL. Performed the
experiments: LD JLGdA AEL JE FR HO BH CH. Analyzed the data:
LD JLGdA AEL JE FR HO BH CH LS FB JPL. Contributed reagents/
materials/analysis tools: LS FB. Wrote the paper: LD JLGdA JPL. Critical
review of the manuscript: AEL JE FR HO BH CH LS FB.
References
1. Gonzalez de Aguilar JL, Echaniz-Laguna A, Fergani A, Rene F, Meininger V, et
al. (2007) Amyotrophic lateral sclerosis: all roads lead to Rome. J Neurochem.
2. Boillee S, Vande Velde C, Cleveland DW (2006) ALS: a disease of motor
neurons and their nonneuronal neighbors. Neuron 52: 39–59.
3. Boillee S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, et al. (2006)
Onset and progression in inherited ALS determined by motor neurons and
microglia. Science 312: 1389–1392.
4. Clement AM, Nguyen MD, Roberts EA, Garcia ML, Boillee S, et al. (2003)
Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in
ALS mice. Science 302: 113–117.
5. Desport JC, Preux PM, Magy L, Boirie Y, Vallat JM, et al. (2001) Factors
correlated with hypermetabolism in patients with amyotrophic lateral sclerosis.
Am J Clin Nutr 74: 328–334.
6. Desport JC, Torny F, Lacoste M, Preux PM, Couratier P (2005) Hypermetab-
olism in ALS: correlations with clinical and paraclinical parameters. Neurode-
generative Dis 2: 202–207.
7. Dupuis L, Corcia P, Fergani A, Gonzalez De Aguilar JL, Bonnefont-Roussel D,
et al. (2008) Dyslipidemia is a protective factor in amyotrophic lateral sclerosis.
Neurology.
8. Funalot B, Desport JC, Sturtz F, Camu W, Couratier P (2008) High metabolic
level in patients with familial amyotrophic lateral sclerosis. Amyotroph Lateral
Scler. pp 1–5.
9. Dupuis L, Oudart H, Rene F, Gonzalez de Aguilar JL, Loeffler JP (2004)
Evidence for defective energy homeostasis in amyotrophic lateral sclerosis:
benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad
Sci U S A 101: 11159–11164.
10. Fergani A, Oudart H, Gonzalez De Aguilar JL, Fricker B, Rene F, et al. (2007)
Increased peripheral lipid clearance in an animal model of amyotrophic lateral
sclerosis. J Lipid Res 48: 1571–1580.
11. Dupuis L, di Scala F, Rene F, de Tapia M, Oudart H, et al. (2003) Up-
regulation of mitochondrial uncoupling protein 3 reveals an early muscular
metabolic defect in amyotrophic lateral sclerosis. Faseb J 17: 2091–2093.
12. Mattson MP, Cutler RG, Camandola S (2007) Energy intake and amyotrophic
lateral sclerosis. Neuromolecular Med 9: 17–20.
13. Hoerter J, Gonzalez-Barroso MD, Couplan E, Mateo P, Gelly C, et al. (2004)
Mitochondrial uncoupling protein 1 expressed in the heart of transgenic mice
protects against ischemic-reperfusion damage. Circulation 110: 528–533.
14. Couplan E, Gelly C, Goubern M, Fleury C, Quesson B, et al. (2002) High level
of uncoupling protein 1 expression in muscle of transgenic mice selectively
affects muscles at rest and decreases their IIb fiber content. J Biol Chem 277:
43079–43088.
15. Ricquier D (2005) Respiration uncoupling and metabolism in the control of
energy expenditure. Proc Nutr Soc 64: 47–52.
16. Han DH, Nolte LA, Ju JS, Coleman T, Holloszy JO, et al. (2004) UCP-mediated
energy depletion in skeletal muscle increases glucose transport despite lipid
accumulation and mitochondrial dysfunction. Am J Physiol Endocrinol Metab
286: E347–353.
17. Jimenez-Mallebrera C, Brown SC, Sewry CA, Muntoni F (2005) Congenital
muscular dystrophy: molecular and cellular aspects. Cell Mol Life Sci 62:
809–823.
18. Gomes MD, Lecker SH, Jagoe RT, Navon A, Goldberg AL (2001) Atrogin-1, a
muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl
Acad Sci U S A 98: 14440–14445.
Denervation and Metabolism
PLoS ONE | www.plosone.org 11 April 2009 | Volume 4 | Issue 4 | e539019. You S, Petrov T, Chung PH, Gordon T (1997) The expression of the low affinity
nerve growth factor receptor in long-term denervated Schwann cells. Glia 20:
87–100.
20. Ridet JL, Malhotra SK, Privat A, Gage FH (1997) Reactive astrocytes: cellular
and molecular cues to biological function. Trends Neurosci 20: 570–577.
21. Kummer TT, Misgeld T, Sanes JR (2006) Assembly of the postsynaptic
membrane at the neuromuscular junction: paradigm lost. Curr Opin Neurobiol
16: 74–82.
22. Schiaveto de Souza A, da Silva CA, Del Bel EA (2004) Methodological
evaluation to analyze functional recovery after sciatic nerve injury.
J Neurotrauma 21: 627–635.
23. Dupuis L, de Tapia M, Rene F, Lutz-Bucher B, Gordon JW, et al. (2000)
Differential screening of mutated SOD1 transgenic mice reveals early up-
regulation of a fast axonal transport component in spinal cord motor neurons.
Neurobiol Dis 7: 274–285.
24. Ripps ME, Huntley GW, Hof PR, Morrison JH, Gordon JW (1995) Transgenic
mice expressing an altered murine superoxide dismutase gene provide an animal
model of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 92: 689–693.
25. Pedersen WA, Mattson MP (1999) No benefit of dietary restriction on disease
onset or progression in amyotrophic lateral sclerosis Cu/Zn-superoxide
dismutase mutant mice. Brain Res 833: 117–120.
26. Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, et al. (2004)
Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man.
Exp Neurol 185: 232–240.
27. Dupuis L, Gonzalez de Aguilar JL, Oudart H, de Tapia M, Barbeito L, et al.
(2004) Mitochondria in amyotrophic lateral sclerosis: a trigger and a target.
Neurodegener Dis 1: 245–254.
28. Dobrowolny G, Aucello M, Rizzuto E, Beccafico S, Mammucari C, et al. (2008)
Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell Metab
8: 425–436.
29. Miller TM, Kim SH, Yamanaka K, Hester M, Umapathi P, et al. (2006) Gene
transfer demonstrates that muscle is not a primary target for non-cell-
autonomous toxicity in familial amyotrophic lateral sclerosis. Proc Natl Acad
Sci U S A 103: 19546–19551.
30. Towne C, Raoul C, Schneider BL, Aebischer P (2008) Systemic AAV6 delivery
mediating RNA interference against SOD1: neuromuscular transduction does
not alter disease progression in fALS mice. Mol Ther 16: 1018–1025.
31. Dupuis L, Gonzalez de Aguilar JL, di Scala F, Rene F, de Tapia M, et al. (2002)
Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis.
Neurobiol Dis 10: 358–365.
32. Hamer PW, McGeachie JM, Davies MJ, Grounds MD (2002) Evans Blue Dye
as an in vivo marker of myofibre damage: optimising parameters for detecting
initial myofibre membrane permeability. J Anat 200: 69–79.
33. Rouaux C, Panteleeva I, Rene F, Gonzalez de Aguilar JL, Echaniz-Laguna A, et
al. (2007) Sodium valproate exerts neuroprotective effects in vivo through
CREB-binding protein-dependent mechanisms but does not improve survival in
an amyotrophic lateral sclerosis mouse model. J Neurosci 27: 5535–5545.
34. Meier T, Marangi PA, Moll J, Hauser DM, Brenner HR, et al. (1998) A
minigene of neural agrin encoding the laminin-binding and acetylcholine
receptor-aggregating domains is sufficient to induce postsynaptic differentiation
in muscle fibres. Eur J Neurosci 10: 3141–3152.
Denervation and Metabolism
PLoS ONE | www.plosone.org 12 April 2009 | Volume 4 | Issue 4 | e5390